BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

809 related articles for article (PubMed ID: 24641480)

  • 41. Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sézary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood staging.
    Feng B; Jorgensen JL; Jones D; Chen SS; Hu Y; Medeiros LJ; Wang SA
    Mod Pathol; 2010 Feb; 23(2):284-95. PubMed ID: 19935642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
    Tan ES; Tang MB; Tan SH
    Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis.
    Diamandidou E; Colome-Grimmer M; Fayad L; Duvic M; Kurzrock R
    Blood; 1998 Aug; 92(4):1150-9. PubMed ID: 9694702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
    Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
    J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Staging and management of cutaneous T-cell lymphoma.
    Scarisbrick JJ
    Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mycosis fungoides--a review of the management of 28 patients and of the recent literature.
    Lenane P; Powell FC; O'Keane C; Dervan P; O'Sullivan D; Bourke E; O'Loughlin S
    Int J Dermatol; 2007 Jan; 46(1):19-26. PubMed ID: 17214715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Folliculotropism Does Not Affect Overall Survival in Mycosis Fungoides: Results from a Single-Center Cohort and Meta-Analysis.
    Giberson M; Mourad A; Gniadecki R
    Dermatology; 2017; 233(4):320-325. PubMed ID: 29169156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group.
    Lamberg SI; Green SB; Byar DP; Block JB; Clendenning WE; Epstein EH; Fuks ZY; Golitz LE; Lorincz AL; Michel B; Roenigk HH; Van Scott EJ; Vonderheid EC; Thomas RJ
    Cancer Treat Rep; 1979 Apr; 63(4):701-7. PubMed ID: 376140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
    Trautinger F; Eder J; Assaf C; Bagot M; Cozzio A; Dummer R; Gniadecki R; Klemke CD; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Whittaker S; Willemze R; Knobler R
    Eur J Cancer; 2017 May; 77():57-74. PubMed ID: 28365528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.
    Quaglino P; Maule M; Prince HM; Porcu P; Horwitz S; Duvic M; Talpur R; Vermeer M; Bagot M; Guitart J; Papadavid E; Sanches JA; Hodak E; Sugaya M; Berti E; Ortiz-Romero P; Pimpinelli N; Servitje O; Pileri A; Zinzani PL; Estrach T; Knobler R; Stadler R; Fierro MT; Alberti Violetti S; Amitay-Laish I; Antoniou C; Astrua C; Chaganti S; Child F; Combalia A; Fabbro S; Fava P; Grandi V; Jonak C; Martinez-Escala E; Kheterpal M; Kim EJ; McCormack C; Miyagaki T; Miyashiro D; Morris S; Muniesa C; Nikolaou V; Ognibene G; Onida F; Osella-Abate S; Porkert S; Postigo-Llorente C; Ram-Wolff C; Ribero S; Rogers K; Sanlorenzo M; Stranzenbach R; Spaccarelli N; Stevens A; Zugna D; Rook AH; Geskin LJ; Willemze R; Whittaker S; Hoppe R; Scarisbrick J; Kim Y
    Ann Oncol; 2017 Oct; 28(10):2517-2525. PubMed ID: 28961843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutaneous T-cell lymphoma.
    Lansigan F; Choi J; Foss FM
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):979-96, x. PubMed ID: 18954747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Value of High-Frequency Ultrasound in Accurate Staging of Mycosis Fungoides/Sézary Syndrome.
    Wang Y; Niu Z; Liu J; Zhu Q; Liu Z; Liu Y; Jin H
    J Ultrasound Med; 2020 Oct; 39(10):1927-1937. PubMed ID: 32319698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides.
    Talpur R; Sui D; Gangar P; Dabaja BS; Duvic M
    Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):49-56. PubMed ID: 26702474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic implications of a bone marrow histopathologic classification system in mycosis fungoides and the Sézary syndrome.
    Graham SJ; Sharpe RW; Steinberg SM; Cotelingam JD; Sausville EA; Foss FM
    Cancer; 1993 Aug; 72(3):726-34. PubMed ID: 8334625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides.
    Tosca A; Linardopoulos S; Malliri A; Hatziolou E; Nicolaidou A; Spandidos DA
    Anticancer Res; 1991; 11(4):1433-8. PubMed ID: 1746900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical staging for cutaneous T-cell lymphoma.
    Lamberg SI; Green SB; Byar DP; Block JB; Clendenning WE; Douglas MC; Epstein EH; Fuks ZY; Golitz LE; Lorincz AL
    Ann Intern Med; 1984 Feb; 100(2):187-92. PubMed ID: 6607008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitation of tumour development correlates with prognosis in tumour stage (stage IIB) mycosis fungoides.
    Boonk SE; Putter H; Koolhof L; Willemze R; Vermeer MH
    Br J Dermatol; 2014 May; 170(5):1080-6. PubMed ID: 24299563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
    Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
    J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
    Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
    Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides.
    van Santen S; Roach RE; van Doorn R; Horváth B; Bruijn MS; Sanders CJ; de Pooter JC; van Rossum MM; de Haas ER; Veraart JC; Bekkenk MW; Vermeer MH; Willemze R
    JAMA Dermatol; 2016 Sep; 152(9):992-1000. PubMed ID: 27276223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.